Matheson Recalls Medical Air Cylinders Due to Carbon Dioxide Impurity
Matheson, Inc. is recalling Medical Air cylinders in Michigan and Wisconsin because they failed impurity specifications for carbon dioxide.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The hazard is a specification failure (carbon dioxide impurity) with no reported illnesses, fitting the criteria for a moderate or low-risk precautionary recall.
Plain-English summary
Matheson, Inc. is recalling 137,880 cubic feet of Medical Air, USP, in various cylinder sizes (E, 22, 40, 200, 220, and 300 cubic feet). The product is a prescription-only respiratory drug distributed in Michigan and Wisconsin.
The recall was initiated because the product failed impurities and degradation specifications, specifically showing out-of-specification results for carbon dioxide. The source text does not report any illnesses or injuries associated with this recall.
Consumers and healthcare providers should stop using the affected lots and contact Matheson, Inc. for further instructions or a replacement. The specific lot numbers affected are listed in the official recall documentation.
The recalled product
- Product
- AIR (AIR)
- Brand
- AIR
- Manufacturer
- Matheson, Inc.
- Category
- Drug — Respiratory Gas
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- A) Lot #: BAHC564281A
- BAHC564281B
- BAHC546288A
- BAHC564288B
- BAHC546288C
- BAHC546288D
- BAHC546288E
- BAHC564307A
- BAHC564314A
- BAHC564329A. BAHC564329B
- BAHC564329C
- BAHC564329D
- BAHC564329E
- BAHC564344A
- BAHC565005A
- BAHC565006A
- BAHC565013A
- BAHC565015A
- BAHC565015B
- BAHC565015C
Distribution
Related recalls
Same hazard · impurity
See all →- ModerateAjanta Pharma Recalls Fluphenazine Hydrochloride Tablets Due to Impurity Failure
FDA (Drugs) · 2026-09-16
- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
Similar recalls
- SevereAirgas Recalls Carbon Dioxide Medical Gas Cylinders Due to Impurities
FDA (Drugs) · 2012-06-20
- ModerateAirgas Recalls Carbon Dioxide Cylinders Due to Labeling Error
FDA (Drugs) · 2013-12-25
- ModerateOklahoma Respiratory Care Recalls Compressed Oxygen Cylinders for Purity Failures
FDA (Drugs) · 2013-07-31
- LowPraxair Recalls Medical Air Cylinders Due to Odor Complaint
FDA (Drugs) · 2016-04-06
- ModeratePraxair Recalls 127 Cylinders of Compressed Medical Air Due to Odor
FDA (Drugs) · 2016-04-06
- ModerateOklahoma Respiratory Care Recalls Compressed Oxygen Cylinders for Testing Failures
FDA (Drugs) · 2012-08-15